KKR will sell USI Insurance Services to Aon for $17 billion in an all-cash transaction, targeting Q4 2026 closing. The deal would provide approximately $3.3 billion of after-tax proceeds and about $2.00 per share of ANI to KKR, underscoring the strong monetization track record of its Strategic Holdings portfolio and the durable cash flows within USI.
KKR has emerged as the preferred bidder to acquire a minority stake in Avisena Healthcare, valuing the business at roughly 1.5 billion ringgit ($370 million). The potential investment underlines KKR's push into APAC healthcare and could extend its Malaysian footprint if closed. Terms and timing are not disclosed, and the transaction remains subject to due diligence and regulatory approvals.
KKR reportedly offered $9 billion to acquire UGI Corp, per WSJ sources. The deal would broaden KKR's energy-infrastructure exposure and may face regulatory and rate-case hurdles, affecting closing timing. If completed, UGI's regulated gas/electric assets could add stable cash flows and potentially support multiple expansion for KKR.
KKR-backed LEAP India's $260 million IPO was fully subscribed by midday on the final bidding day, led by non-institutional investors. The strong retail and non-institutional demand underscores appetite for tech-focused platforms in India and may help KKR diversify its exits and capital deployment in the region. The result could bolster KKR's India venture credibility and attract follow-on capital.
KKR announced definitive agreements to acquire Medicover India's hospital operations from Medicover AB, marking a strategic expansion of its healthcare platform in India. The deal, still subject to regulatory approvals, leverages Medicover India's 24-hospital footprint with ~4,800 beds and 1,900 doctors across 80+ specialties. KKR frames the investment as boosting talent, technology, infrastructure, and governance to improve patient care and access over the long term.
Dutch bike maker Accell Group has begun insolvency proceedings after failing to meet financial obligations amid a prolonged downturn in Europe’s bike market. The move raises liquidity concerns and could trigger creditor-led restructuring or asset sales. If KKR holds an Accell stake or debt, impairment risk could affect PE portfolio valuations; otherwise the impact is more indirect.